Fisher & Paykel Healthcare Corporation Ltd
XBER:FPLB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fisher & Paykel Healthcare Corporation Ltd
XBER:FPLB
|
NZ |
|
A
|
Autobacs Seven Co Ltd
SWB:AB6
|
JP |
|
H
|
HeidelbergCement AG
F:HEI
|
DE |
|
C
|
Central Pacific Financial Corp
F:XCP1
|
US |
|
B
|
Basf Se
XMUN:BAS
|
DE |
|
G
|
Gibraltar Industries Inc
XMUN:GI2
|
US |
|
A
|
Alps Alpine Co Ltd
F:ALE
|
JP |
|
A
|
Aurubis AG
XMUN:NDA
|
DE |
|
Toyo Seikan Group Holdings Ltd
F:TQN
|
JP |
|
V
|
VKTR Teknologi Mobilitas Tbk PT
IDX:VKTR
|
ID |
|
Grupo Aeroportuario del Centro Norte SAB de CV
F:G7A
|
MX |
|
L
|
Lineage Cell Therapeutics Inc
AMEX:LCTX
|
US |
|
K
|
KGL Resources Ltd
F:KN6
|
AU |
|
S
|
Safran SA
F:SEJ1
|
FR |
Wall St Price Targets
FPLB Price Targets Summary
Fisher & Paykel Healthcare Corporation Ltd
According to Wall Street analysts, the average 1-year price target for FPLB is 23.98 EUR with a low forecast of 20.59 EUR and a high forecast of 27.94 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FPLB's stock price target?
Price Target
23.98
EUR
According to Wall Street analysts, the average 1-year price target for FPLB is 23.98 EUR with a low forecast of 20.59 EUR and a high forecast of 27.94 EUR.
What is the Revenue forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 3 years is 20%.
